Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

103.43p
   
  • Change Today:
      0.43p
  • 52 Week High: 109.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 5,140
  • Market Cap: £87.58m
  • RiskGrade: 196

Diaceutics Overview

Diaceutics is a data analytics and implementation services company which services the global pharmaceutical industry. It has established a suite of data-driven products and implementation services powered by the data held in its proprietary database. Its products and services are focused on optimising its clients’ strategies for the development and launch of precision medicines and specifically, the diagnostic testing required to guide selection of such medicines. The Group currently provides services to 20 of the 30 largest global pharmaceutical companies.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 2.9% n/a
ROCE 2.0%  
Latest F'cast
P/E 119.8 n/a
PEG 4.2 n/a
Pr/Revenue 4.5 n/a
Pr/Book 2.1  
Latest F'cast
Revenue 39.9% n/a
PBT 22.1% n/a
EPS 28.4% n/a
DPS n/a n/a

Diaceutics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 10.37 0.88 1.86p n/a n/a n/a n/a 0.0%
31-Dec-19 13.44 0.50 2.46p 41.5 1.3 +32% n/a 0.0%
31-Dec-20 12.70 (0.68) 0.74p 180.4 n/a -70% n/a 0.0%
31-Dec-21 13.94 0.46 0.67p 152.2 n/a -10% n/a 0.0%
31-Dec-22 19.50 0.56 0.86p 87.8 3.1 +28% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Diaceutics Company Announcements

Appointment of Amie Mc Neice as VP of Marketing 09-Apr-2024 07:00 RNS
Block Listing Return 05-Apr-2024 13:40 RNS
PDMR Shareholding/Share Incentive Plan 03-Apr-2024 07:00 RNS

Latest Diaceutics Director Deals

Traded Action Notifier PriceAmountValue
28-Mar-24 Sell Peter Keeling 102.00p 750,000 £764,999.99
28-Mar-24 Sell Peter Keeling 102.00p 750,000 £764,999.99
06-Mar-24 Buy Graham Paterson 98.50p 33,564 £33,060.54

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 103.43p
Change Today 0.43p
% Change 0.42 %
52 Week High 109.00
52 Week Low 80.50
Volume 5,140
Shares Issued 84.68m
Market Cap £87.58m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.87% below the market average90.87% below the market average90.87% below the market average90.87% below the market average90.87% below the market average
74.19% below the sector average74.19% below the sector average74.19% below the sector average74.19% below the sector average74.19% below the sector average
Price Trend
40.40% above the market average40.40% above the market average40.40% above the market average40.40% above the market average40.40% above the market average
51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average
Income Not Available
Growth
3.20% above the market average3.20% above the market average3.20% above the market average3.20% above the market average3.20% above the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average

Diaceutics Dividends

No dividends found

Trades for 16-Apr-2024

Time Volume / Share Price
09:39 5,000 @ 103.50p
08:14 140 @ 103.90p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page